Pyxis Oncology (PYXS) News Today → SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad) Free PYXS Stock Alerts $4.50 -0.03 (-0.66%) (As of 04/23/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlinePYXS Oct 2024 10.000 callfinance.yahoo.com - April 14 at 8:10 PMBuy Rating Affirmed for Pyxis Oncology as PYX-201 Showcases Promising Preclinical Data and Broad Therapeutic Potentialmarkets.businessinsider.com - April 10 at 3:10 PMPyxis Oncology (NASDAQ:PYXS) Receives Buy Rating from HC Wainwrightmarketbeat.com - April 10 at 8:17 AMWhy Ulta Beauty Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Sessionmsn.com - April 3 at 3:11 PMPyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)globenewswire.com - March 28 at 4:30 PMAnalysts Offer Insights on Healthcare Companies: Aura Biosciences Inc (AURA), Spectral AI (MDAI) and Pyxis Oncology (PYXS)markets.businessinsider.com - March 28 at 10:35 AMPyxis Oncology: Data Arriving Later Than Expected, But May Be Worth The Waitseekingalpha.com - March 28 at 10:35 AM3 Biotech Stocks to Buy on the Dip: March 2024investorplace.com - March 27 at 1:07 PMPyxis Oncology gets $8M payment for sale pf royalty rightsmsn.com - March 27 at 9:23 AMPyxis Oncology Obtains $8 Million Payment for the Sale of Royalty Rightsglobenewswire.com - March 27 at 7:30 AMOptimistic Buy Rating for Pyxis Oncology’s PYX-201 Based on Strong Safety Profile and Promising Therapeutic Potentialmarkets.businessinsider.com - March 25 at 4:33 AMBuy Rating Affirmed for Pyxis Oncology on Strong Clinical and Financial Prospectsmarkets.businessinsider.com - March 22 at 4:41 PMPyxis Oncology (NASDAQ:PYXS) Receives "Outperform" Rating from Royal Bank of Canadamarketbeat.com - March 22 at 11:45 AMPyxis Oncology (NASDAQ:PYXS) Given New $7.00 Price Target at HC Wainwrightmarketbeat.com - March 22 at 8:17 AMBuy Rating Affirmed: Pyxis Oncology’s Financial Health and Promising Drug Candidate PYX-201 Bolster Optimismmarkets.businessinsider.com - March 22 at 1:33 AMPyxis Oncology Shares Fall 10% After Apparent Delay in Resultsmarketwatch.com - March 21 at 3:32 PMPYXS Stock Earnings: Pyxis Oncology Beats EPS for Q4 2023investorplace.com - March 21 at 2:05 PMPyxis Oncology: Q4 Earnings Insightsbenzinga.com - March 21 at 10:32 AMPyxis Oncology Inc (PYXS) Reports Encouraging Clinical Progress Amid Financial Challengesfinance.yahoo.com - March 21 at 10:32 AMPyxis Oncology (PYXS) to Release Quarterly Earnings on Fridaymarketbeat.com - March 21 at 7:37 AMPyxis Oncology Provides Corporate Update and Reports Financial Results for Fourth Quarter and Full Year 2023globenewswire.com - March 21 at 7:30 AMFrom Six Figures to Seven: 3 Biotech Stocks Set to Make Millionairesinvestorplace.com - March 19 at 2:58 PMPyxis Oncology (PYXS) Receives a Buy from Leerink Partnersmarkets.businessinsider.com - March 19 at 8:11 AMPYXS Apr 2024 10.000 callfinance.yahoo.com - March 17 at 11:03 AMPYXS Apr 2024 7.500 putfinance.yahoo.com - March 17 at 11:03 AMPYXS Jul 2024 7.500 callfinance.yahoo.com - March 15 at 8:52 PM326,810 Shares in Pyxis Oncology, Inc. (NASDAQ:PYXS) Acquired by Decheng Capital Management III Cayman LLCmarketbeat.com - March 13 at 8:45 AMPyxis Oncology Expands Board of Directors with Appointment of Santhosh Palani, Ph.D., CFAglobenewswire.com - March 13 at 8:00 AMPyxis Oncology to Present at Leerink Global Biopharma Conference 2024globenewswire.com - March 7 at 4:30 PMPyxis Oncology to Present New PYX-201, PYX-106 and PYX-102 Preclinical Data at AACR Annual Meetingglobenewswire.com - March 5 at 4:45 PMPyxis Oncology Shares Up 21% in Premarket Trading on $50M Fundraisemarketwatch.com - February 27 at 10:30 AMPyxis Oncology Announces $50 Million Private Placementfinance.yahoo.com - February 27 at 10:30 AMPyxis Oncology Stock (NASDAQ:PYXS) Dividends: History, Yield and Datesbenzinga.com - February 23 at 9:57 PMPyxis Oncology Stock (NASDAQ:PYXS), Analyst Ratings, Price Targets, Predictionsbenzinga.com - February 23 at 9:57 PM3 Biotech Stocks to Turn $10,000 Into $1 Million: February 2024investorplace.com - February 22 at 6:00 PMPyxis Oncology, Inc. (NASDAQ:PYXS) Receives Consensus Rating of "Buy" from Analystsmarketbeat.com - February 17 at 1:37 AMBuy Rating for Pyxis Oncology: Advancing ADC Innovation and Immuno-Oncology Pipelinemarkets.businessinsider.com - February 9 at 11:12 PMBTIG Research Initiates Coverage on Pyxis Oncology (NASDAQ:PYXS)marketbeat.com - February 9 at 7:20 AMPyxis Oncology, Inc. (NASDAQ:PYXS) to Post FY2023 Earnings of ($2.05) Per Share, Leerink Partnrs Forecastsmarketbeat.com - January 25 at 6:52 AMPyxis Oncology's (PYXS) Outperform Rating Reaffirmed at Leerink Partnrsmarketbeat.com - January 25 at 6:42 AMPyxis Oncology, Inc. (NASDAQ:PYXS) Receives Consensus Recommendation of "Buy" from Analystsmarketbeat.com - January 23 at 10:38 AMPyxis Oncology (NASDAQ:PYXS) Research Coverage Started at SVB Leerinkmarketbeat.com - January 23 at 8:22 AMIndividual investors among Pyxis Oncology, Inc.'s (NASDAQ:PYXS) largest shareholders, saw gain in holdings value after stock jumped 18% last weekfinance.yahoo.com - January 12 at 6:33 AMHC Wainwright & Co. Initiates Coverage of Pyxis Oncology (PYXS) with Buy Recommendationmsn.com - December 1 at 8:32 AMPyxis Oncology announces appointment of Kobayashi as CMOmsn.com - November 28 at 10:26 AMPyxis Oncology Names Ken Kobayashi Chief Medical Officermarkets.businessinsider.com - November 28 at 10:26 AMPyxis Oncology Announces Appointment of Ken Kobayashi, M.D., F.A.C.P as Chief Medical Officerfinance.yahoo.com - November 28 at 10:26 AMThinking about buying stock in Nio Inc, SoundHound AI, Meta Platforms, Pyxis Oncology, or Tivic Health Systems?benzinga.com - November 16 at 10:41 AMRBC Capital Reaffirms Their Buy Rating on Pyxis Oncology (PYXS)markets.businessinsider.com - November 11 at 3:21 PMLifeSci Capital Reaffirms Their Buy Rating on Pyxis Oncology (PYXS)markets.businessinsider.com - November 8 at 11:42 PM Get Pyxis Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for PYXS and its competitors with MarketBeat's FREE daily newsletter. Email Address Exposed: 10 CENT Crypto to Explode April 20th? (Ad)Former Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than Bitcoin Click For My #1 FREE Crypto for 2024 PYXS Media Mentions By Week PYXS Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PYXS News Sentiment▼0.000.46▲Average Medical News Sentiment PYXS News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PYXS Articles This Week▼01▲PYXS Articles Average Week Get Pyxis Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for PYXS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: XBIT News NKTR News PRLD News VSTM News KMDA News AQST News RAPT News XOMA News AEON News NBTX News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PYXS) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersSHOCKING Crypto Leak…Crypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingMan Who Predicted 2008: “This Will be Worse.”AltimetryThe Next Nvidia?InvestorPlaceExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersGreat Crypto BullWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pyxis Oncology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
